HOME>HOME>About ASKA Pharmaceutical Holdings>ASKA Pharmaceutical Holdings in Numbers

ASKA Pharmaceutical Holdings in Numbers

Foundation
創立アイコン

104years

(Founded in 1920)

Female Medicine Research
女性医療研究アイコン

100years

* Over 100 years

Ob/Gyn* field
産婦人科領域アイコン

Top share in Japan

Leading Company

※In-house estimate

Thyroid field
甲状腺領域アイコン

Top share in Japan

95%

Consolidated Sales
連結売上高アイコン

62.8

billion yen

(FY2023)

  • ASKA Pharmaceutical 56.0 billion yen
    (Pharamaceutical business)
  • ASKA Animal Health 6.6 billion yen
    (Animal health business)
  • ASKA Pharma Medical 0.16 billion yen
    (Testing business)
Number of Employees
従業員数アイコン

762

(End of FY2023)

Major business sites
主要事業所アイコン

23

Including 1 international site

Operating profit margin
営業利益率アイコン

10.3

(FY2023)

ROE(Return on Equity)
ROE(自己資本純利益率)アイコン

13.0

(FY2023)

Dividend payout ratio
配当性向アイコン

30

(Benchmark ratio)
*A minimum annual dividend per
share of 30 yen

R&D expenses
研究開発費アイコン

4.7 
billion yen

(FY2023)
*ASKA Pharmaceutical

Promotion of Women's advancement
女性活躍推進アイコン

Ratio of female
employees

32.7

Ratio of female management positions

11.4

Ratio of female management candidates

23.0

(End of FY2023 in ASKA Pharmaceutical)

Ratio of male employees taking child care leave
男性育児休業取得率アイコン

100.0

(FY2023 in ASKA Pharmaceutical)

Reduction rate of Total CO₂ Emissions
CO₂排出削減率アイコン

49.2

* The rate in FY2023 compared with the rate in FY2013